MSLN and neoplasm: As advanced stages and residual tumour volume have been shown to correlate with the chemoresponse of EOC patients, there was additional focus on the 104 advanced-stage patients, who were divided into two groups – those with and those without optimal debulking surgery – to evaluate the correlations between mesothelin expression and chemoresponse.